MVision’s Guideline-Based AI Segmentation is Available in the EduCase Platform

Helsinki – 19th of January, 2022 – MVision AI, the leading provider of the guideline-based solution, collaborates with EduCase, the global leader in web-based education designed to support contouring skill instructions for radiation oncologists. EduCase is a computer-based training tool developed by RadOnc eLearning Center, LLC., to assist the development of structure segmentation (contouring) skills of radiation oncologists, medical physicists, and dosimetrists. 

The educational collaboration entitles EduCase to include MVision’s guideline-compliant AI segmentation, GCAIS™, software in all teaching sessions. This supplements students with hands-on experience working with MVision’s state-of-the-art solution. The MVisionaries will support EduCase to help educate the students, providing them with the unique opportunity to work with our groundbreaking AI models. 

“We are excited to be working with and delivering this new EdTech feature by integrating MVision’s AI segmentation guideline structures into the EduCase contour training platform. We are seeing significant demand in AI training in radiotherapy, and its impact and influence on the  educational ecosystem of Radiation Oncology, Contouring, and Education.” said Scott Kaylor: Co-Founder of EduCase

“Advancements of AI in Radiotherapy are redefining the role of clinicians. Education and training are becoming essential for clinicians to deliver high-quality treatment. Through our collaboration with EduCase, MVision is very excited to bring AI models to the EduCase platform to further accelerate the adoption of this novel technology” said Mahmudul Hasan: Co-Founder and CEO of MVision AI 

Discover EduCase

Website: https://www.educase.com/ 

LinkedIn: https://www.linkedin.com/company/radonc-elearning-center-inc./ 

Are you eager to explore GCAIS™? Request a demo here. 

MVision AI is active on LinkedIn, Twitter, Facebook, and Instagram. Follow us on social media and subscribe to our newsletter to stay up-to-date on the latest MVision AI news.

Welcome you to contact MVision AI:

c/o Terkko Health Hub, Haartmaninkatu 4, 00290 Helsinki, Finland.

Tel: +358 (0) 40 5489 229

Website: https://www.mvision.ai 

Email: info@mvision.ai 

For media inquiries:

Tel: +358 40 500 7915

Email: pr@mvision.ai

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI

Related Posts

13.12.2024

Saad Ullah Akram Appointed as CEO of MVision AI

Helsinki, Finland – MVision AI, a leading provider of AI-powered solutions for radiation therapy treatment planning, announces the appointment of Saad Ullah Akram as its new Chief Executive Officer. Known for its commitment to streamlining workflows and enhancing treatment quality in cancer care, MVision AI is embarking on an exciting…

Press Releases

20.11.2024

MVision AI Ranked Among the Top 10 in Deloitte Technology Fast 50 Finland for 2024

Helsinki, Finland, 20 November 2024 – MVision AI, a leading innovator in AI-driven solutions for oncology, is proud to announce its recognition among the top ten companies in the Deloitte Technology Fast 50 Finland 2024 ranking. This prestigious award acknowledges MVision AI's rapid growth and its mission-driven advancements in making…

Press Releases

7.11.2024

Safe and Ethical AI in Radiation Oncology: Regulations and MVision’s Compliance

Technology is evolving, and the same applies to Radiation Oncology. New ways and new tools require new rules. Artificial intelligence (AI)  brings tremendous potential, so the world has to learn how to get the best of it, safely.  Al systems identified as high-risk have to comply with strict requirements, including…

Articles